Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nityanand Jain has a total of 373 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Heart rate variability associated with cardiometabolic risk factors in Ghanaian adults with hypertension: A quantile regression analysis

    by Bismark Osei Owusu, Ernest Kissi Kontor, Nityanand Jain, Francis Abeku Ussher, Cornelius Assan, Henry Kyei Baffour, Stephen Atta Nyarko, Derrick Acheampong Adjei, Benjamin Tutu Asare, Daniel Boateng

  • Open Access

    What makes a study limitation? An inference-first approach to reporting uncertainty

    by Nityanand Jain, Mara Pilmane

    Limitations reporting in biomedical manuscripts has become increasingly formulaic — recognizable design features are often listed as weaknesses whether or not they materially alter interpretation. We argue that the problem is conceptual before it is structural. A methodological characteristic becomes a limitation only when it constrains inference, increases relevant uncertainty, or narrows the intended applicability of a claim. Herein, we distinguish finding-level constraints from study-level questions of scope and applicability, rather than treating both as generic study weaknesses. We further consider how current writing and peer-review practices may encourage ritualized limitations disclosure. These practices include defensive accumulation of limitations, Discussion sections dominated by serial literature comparisons, and post-hoc expansion of inferential scope. Recent suggestions of (semi-) structured limitation-reporting frameworks may help prompt reflection, but they should not become editorial gatekeeping tools, quality proxies, self-administered risk-of-bias instruments, or fixed boundaries around inquiry. Furthermore, such checklists should not become formalized limitation labels that may imply that work from smaller or specialized settings is intrinsically less informative. We propose an alternative approach — begin with the inference, identify which study features constrain it and by what mechanism, place uncertainty where it modifies interpretation, and reclaim the Discussion for critical reasoning.

  • Open Access

    Global Programmatic Survey on Governance and Surveillance of Nontuberculous Mycobacteria

    by Nityanand Jain, Liga Kuksa, Dissou Affolabi, Fabiola Eliosa Arias Munoz, Angelica Scappaticcio, Sushil Pandey, Lisa Shephard, Rumina Hasan, Lorenzo Guglielmetti, Gert-Jan Wijnant, et al.

    Background: Nontuberculous mycobacteria (NTM) are clinically important pathogens but often weakly positioned within health systems, with unclear institutional ownership, variable notification arrangements, and limited surveillance visibility. Methods: We conducted a multilingual online survey among programme-facing national and subnational mycobacterial stakeholders from November to December 2025. Using an adaptive hierarchical recruitment strategy, we targeted 217 countries and jurisdictions. One response per programme was requested. We assessed institutionalisation, notification, agenda maturity, thematic discussion priorities, and barriers to action. We also derived relative policy momentum from three urgency domains (diagnostics, clinical management, and surveillance) using within-WHO region hierarchical clustering. Findings were used to develop a heuristic roadmap for staged NTM governance and system visibility. Results: We received 193 programme-level responses, including from subnational jurisdictions, representing 171 of 217 targeted countries (78.8% jurisdictional coverage). NTM institutionalisation status was heterogeneous: 34% reported NTM integration within the NTP, while 37% expressed intents to institutionalise within the NTP in nearest future. Mandatory notification was reported by 21% of programme units, voluntary notification by 10%, and notification under consideration by 24%. NTM appeared to enter policy discussions along a gradient, with clinical management and diagnostics attracting earlier attention than surveillance, training needs, and financing. Globally, pulmonary NTM was discussed more frequently than extrapulmonary disease. Across WHO regions, policy momentum clustering separated programmes into higher and lower profiles, with surveillance consistently being the weakest domain. Financing and lack of epidemiological data were identified as the most actionable barriers. There was broad support for TB-NTM surveillance integration. Conclusions: NTM governance is heterogeneous and frequently weakly anchored globally. The findings do not support a single universal institutional model; rather, existing mycobacterial platforms may provide pragmatic starting points for improving programme visibility, coordination, and reporting. The proposed heuristic roadmap outlines staged governance options according to burden, capacity, and institutional context.

  • Open Access

    Clofazimine use for nontuberculous mycobacterial infections: 10-year experience in Belgium

    by Astrid Piot, Sophie Missault, Yannick Vande Weygaerde, Nityanand Jain, Pascal Van Bleyenbergh, Cedric Bosteels, Isabel Spriet, Franky Buyle, Eva Van Braeckel, Natalie Lorent

    Clofazimine is increasingly recommended for nontuberculous mycobacterial (NTM) infections, despite limited evidence. In Belgium, until July 2025 access to

  • Open Access

    Computed Tomography-Based Morphometric Analysis of the Ascending Aorta in Acute Type A Dissection Beyond Diameter-Based Thresholds: A National Cohort Study from Latvia

    by Ivars Brecs, Sandra Skuja, Simons Svirskis, Nityanand Jain, Peteris Stradins

    Background/Objectives: Ascending aortic aneurysm is a heterogeneous disease, with many cases of acute Stanford type A aortic dissection (ATAAD) presenting with aortic diameters below currently recommended surgical thresholds. Demographic factors such as age and sex, along with indexed aortic size groups, have been proposed to improve risk stratification. Methods: We included 65 adult patients who underwent surgical intervention for ATAAD. Morphometric measurements were obtained from computed tomography angiography (CTA) using centerline reconstruction. Maximum ascending aortic diameter and length were measured. Indexed parameters included the aortic size index (ASI), aortic height index (AHI), aortic length index (ALI) and cross-sectional aortic area indexed to height (CSA/H). Estimated pre-dissection dimensions were derived by reducing diameter by 18% and length by 2.7%. The cohort was stratified by age-, sex-, and ASI-defined groups. Results: Women were older than men (mean age 67 [SD 11] vs. 58 [SD 13] years, p = 0.01). Aortic diameter and length did not differ significantly by age or sex. At presentation, an ascending aortic diameter < 5.0 cm was observed in 37.1% of patients aged < 65 years and 26.7% of those aged ≥ 65 years. When stratified by sex, 25.0% of women and 35.6% of men presented with an ascending aortic diameter < 5.0 cm. Indexed parameters (ALI, AHI and ASI) were higher in older patients and women despite their smaller body size. In estimated pre-dissection analyses, less than 10% of the patients had diameters ≥ 5.5 cm, whereas most had estimated diameters < 5.0 cm. Conclusions: A substantial proportion of patients with ATAAD present with aortic dimensions below the current surgical thresholds. These findings underscore the limitations of diameter-based criteria and support the potential value of indexed geometric parameters in improving risk assessment in ATAAD patients.


  • Open Access

    Recovery of adrenal function in a patient with iatrogenic adrenal insufficiency temporally associated with methamphetamine use: a case report

    by Hester Lacey, Nityanand Jain, Mohamed Eloofy, Deborah Williams, Ali Chakera

    Introduction: Iatrogenic adrenal insufficiency is a recognized complication of prolonged, high-dose exogenous glucocorticoid therapy and may result in persistent dependence on replacement therapy. We report a case of apparent recovery of adrenal function temporally associated with methamphetamine self-administration in a patient with prolonged glucocorticoid-induced adrenal suppression. Case presentation: We describe the case of a Caucasian man who developed persistent adrenal insufficiency following a skiing accident with a cervical C3/4 fracture, for which he received hydrocortisone during a 13-month hospitalization episode. After glucocorticoid withdrawal, he developed symptoms consistent with adrenal insufficiency, which were supported by short Synacthen testing. Hydrocortisone replacement therapy was initiated at 10/5/5 mg daily regimen, but symptom control remained poor despite dose escalation and repeated rescue intramuscular hydrocortisone injections for recurrent adrenal crises. After three years of replacement therapy, the patient independently initiated using crystal methamphetamine in an attempt to relieve symptoms. He subsequently reported symptomatic improvement, reduced frequency of adrenal crises, and gradual weaning of hydrocortisone requirements. This was temporally associated with progressive recovery of endogenous adrenal function on serial short Synacthen testing. One year later, hydrocortisone had been discontinued, serum cortisol levels had improved into the normal range, and symptoms had resolved. At the latest follow-up, he remained off regular hydrocortisone and had also discontinued methamphetamine use. Discussion and Conclusions: This case demonstrates a possible temporal association between methamphetamine self-use and apparent clinical and biochemical recovery from iatrogenic adrenal insufficiency. However, causality cannot be inferred, and alternative explanations, including delayed spontaneous recovery, cannot be ruled out. Learning points:

  • Open Access

    Treatment outcomes and long-term relapse-free survival after multidrug-resistant tuberculosis treatment in Latvia: a retrospective national cohort study

    by Sophie Charlotte Meier, Liga Kukša, Santa Ķauķe, Vija Riekstina, Evita Biraua, Nityanand Jain, Christoph Lange, Thomas Theo Brehm


  • Open Access

    Nipah virus on the radar: The choice to catch early or catch up later

    by Hester Lacey, Shivani Jain, Aigars Reinis, Nityanand Jain

  • Open Access

    Decision Letters from a Kyrgyz Research Ethics Committee (2018–2022): An Empirical Review of Transparency, Rigor, and Communication

    by Tamara Kudaibergenova, Nityanand Jain

    Research Ethics Committees (RECs) safeguard participants, yet little is known about how their decisions are communicated to study investigators in low- and middle-income countries (LMICs). We analysed 138 decision letters from a public-health REC in Kyrgyzstan (2018–2022) using descriptive statistics and documentary review. REC panel consisted predominantly of clinical and biomedical experts, with identifying data missing for 51% ( n = 506/991) of panelists. Lay member participation was absent despite being mandated in SOPs. The first-review approval rate was 55.1%. Communication in decision letters tended to be prescriptive rather than advisory, with critical ethical deficiencies often not flagged. Furthermore, there was a lack of explicit citation of national or international guidance. Our observations point to opportunities to improve transparency, review quality, and stakeholder engagement through standardized templates, targeted reviewer training, and the inclusion of lay members. Strengthening these practices may enhance consistency, quality, and trust in REC decision-making in comparable post-Soviet LMICs contexts.

  • Medicinal and Nutritional Importance of Cymbopogon citratus in Human Health

    by Abdelmonem Siddiq, Manisha Das, Muhammed Shabil, Shubham Shrestha, Swarali Yatin Chodnekar, Nityanand Jain